Friday, May 29, 2015

Are Insurers Prevailing Over Drug Makers?

Less than a year ago, it looked like health insurers were sending up trial balloons to see if they could get the federal government to regulate the research-based pharmaceutical industry as a utility. This was a reaction to high prices for new drugs like Sovaldi®. Today, the issue is being dialed back.

Read the entire entry at NCPA's Health Policy Blog.

No comments: